However, the fundamental limitation is that a subpopulation of metastatic tumor cells undergoing epithelial-to-mesenchymal transition will lose EpCAM expression [18], while some leukocytes may be activated for EpCAM [19], causing inaccurate detection using this approach. Here, EPCAM is linked to neoplasm.